Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO(TM), a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
The joint venture, Angelini Labopharm, will be 50 percent owned by each of Labopharm and Angelini and will be initially managed by Mary Anne Heino, President of Labopharm’s US Operations, and her team.
[BioSpace]
Boeing Co. won a long-sought decision by the Navy to keep buying its F/A-18 Super Hornet for several years after the company knocked 10% off the fighter jet’s price, saving the ... Read More
Astellas Pharma Inc., Japan’s No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its ... Read More
Two of St. Louis’ major powerhouses announced a unique partnership today whose purpose is to discover new uses for existing drugs and to accelerate the development of scientific knowledge about human ... Read More
Gov. Jay Nixon today took part in the official announcement that global technology innovator IBM will locate a new services delivery center in Columbia, a project that will create 800 new ... Read More
Phycal LLC has leased 2,800 square feet for an algae biotechnology laboratory at the BioResearch and Development Growth Park (BRDG) at the Danforth Plant Science Center. Phycal, led by President and ... Read More
Four Missouri metros ranked in the top 50% of 366 metros due to the strength of their economies. Kansas City ranked 17th, followed by St. Louis at 101st, Springfield at 162nd, ... Read More
Merck & Co. plans to file five new drug applications this year but said it has ended development of its first stab at a follow-on biologic drug, illustrating the risks of ... Read More
Genetic tests that assess a person’s risk of getting various diseases are heading to the corner drug store. Pathway Genomics, a start-up company, is expected to announce on Tuesday that it ... Read More
Samsung said on May 11 that it plans to invest $20 billion in healthcare and green energy until 2020 in a move it says could provide thousands of new jobs. Among ... Read More
Best known for its Quicken software, Intuit is moving further into the health care market through a new acquisition. Intuit announced Tuesday that it will pay $91 million in cash to ... Read More